David Hickey - 26 Nov 2021 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & President, Life Sciences
Signature
Richard Stout, by power of attorney for David Hickey
Issuer symbol
BDX
Transactions as of
26 Nov 2021
Net transactions value
+$370,331
Form type
4
Filing time
30 Nov 2021, 11:42:19 UTC
Previous filing
08 Sep 2021
Next filing
10 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +1,473 +41% $0.000000 5,059 26 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDX Rights to Common Stock Under 1996 Directors Deferral Plan Award $370,331 +1,511 +39% $245.09 5,366 26 Nov 2021 Common Stock 1,511 Direct F2, F3
transaction BDX Stock Appreciation Rights Award $0 +10,522 $0.000000 10,522 26 Nov 2021 Common Stock 10,522 $245.09 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 The securities convert to common stock on a one-for-one basis.
F3 The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.
F4 The stock appreciation rights vest in four annual installments beginning November 26, 2022.